Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

What will studies of Fulani individuals naturally exposed to malaria teach us about protective immunity to malaria?

M. Troye-Blomberg, C. Arama, J. Quin, I. Bujila, AK. Östlund Farrants,

. 2020 ; 92 (4) : e12932. [pub] -

Language English Country Great Britain

Document type Journal Article, Review

Grant support
PD00217ML Wellcome Trust - United Kingdom
242059 European Community Seventh Framework Programme (FP7)
LSHP-CT-2004-503578 BioMalPar European Network of Excellence
107740/Z/15/Z9 DELTAS Africa Initiative
UK Government
New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency)
Wellcome Trust - United Kingdom

E-resources Online Full text

NLK Free Medical Journals from 1997 to 1 year ago
Medline Complete (EBSCOhost) from 1972-01-01 to 1 year ago
Wiley Free Content from 1997 to 1 year ago

There are an estimated over 200 million yearly cases of malaria worldwide. Despite concerted international effort to combat the disease, it still causes approximately half a million deaths every year, the majority of which are young children with Plasmodium falciparum infection in sub-Saharan Africa. Successes are largely attributed to malaria prevention strategies, such as insecticide-treated mosquito nets and indoor spraying, as well as improved access to existing treatments. One important hurdle to new approaches for the treatment and prevention of malaria is our limited understanding of the biology of Plasmodium infection and its complex interaction with the immune system of its human host. Therefore, the elimination of malaria in Africa not only relies on existing tools to reduce malaria burden, but also requires fundamental research to develop innovative approaches. Here, we summarize our discoveries from investigations of ethnic groups of West Africa who have different susceptibility to malaria.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20027797
003      
CZ-PrNML
005      
20210114152402.0
007      
ta
008      
210105s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/sji.12932 $2 doi
035    __
$a (PubMed)32652609
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Troye-Blomberg, Marita $u Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
245    10
$a What will studies of Fulani individuals naturally exposed to malaria teach us about protective immunity to malaria? / $c M. Troye-Blomberg, C. Arama, J. Quin, I. Bujila, AK. Östlund Farrants,
520    9_
$a There are an estimated over 200 million yearly cases of malaria worldwide. Despite concerted international effort to combat the disease, it still causes approximately half a million deaths every year, the majority of which are young children with Plasmodium falciparum infection in sub-Saharan Africa. Successes are largely attributed to malaria prevention strategies, such as insecticide-treated mosquito nets and indoor spraying, as well as improved access to existing treatments. One important hurdle to new approaches for the treatment and prevention of malaria is our limited understanding of the biology of Plasmodium infection and its complex interaction with the immune system of its human host. Therefore, the elimination of malaria in Africa not only relies on existing tools to reduce malaria burden, but also requires fundamental research to develop innovative approaches. Here, we summarize our discoveries from investigations of ethnic groups of West Africa who have different susceptibility to malaria.
650    _2
$a lidé $7 D006801
650    _2
$a tropická malárie $x epidemiologie $x imunologie $7 D016778
651    _2
$a subsaharská Afrika $7 D017954
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Arama, Charles $u Department of Epidemiology of Parasitic Diseases, International Center of Excellence in Research, Malaria Research and Training Centre, University of Sciences, Technique and Technology of Bamako, Bamako, Mali.
700    1_
$a Quin, Jaclyn $u Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden. CEITEC Masaryk University, Brno, Czech Republic.
700    1_
$a Bujila, Ioana $u Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden. Department of Microbiology, Public Health Agency of Sweden, Solna, Sweden.
700    1_
$a Östlund Farrants, Ann-Kristin $u Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.
773    0_
$w MED00010600 $t Scandinavian journal of immunology $x 1365-3083 $g Roč. 92, č. 4 (2020), s. e12932
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32652609 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114152400 $b ABA008
999    __
$a ok $b bmc $g 1608132 $s 1118977
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 92 $c 4 $d e12932 $e - $i 1365-3083 $m Scandinavian journal of immunology $n Scand J Immunol $x MED00010600
GRA    __
$a PD00217ML $p Wellcome Trust $2 United Kingdom
GRA    __
$a 242059 $p European Community Seventh Framework Programme (FP7)
GRA    __
$a LSHP-CT-2004-503578 $p BioMalPar European Network of Excellence
GRA    __
$a 107740/Z/15/Z9 $p DELTAS Africa Initiative
GRA    __
$p UK Government
GRA    __
$p New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency)
GRA    __
$p Wellcome Trust $2 United Kingdom
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...